Among patients with incompletely excised basal cell carcinoma (BCC), only about 16% with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in ...

Immediate nasal reconstruction post-BCC excision does not elevate re-excision or recurrence risk, supporting its viability. The study analyzed 318 cases, showing no significant difference in ...

Mohs micrographic surgery (MMS) is considered the gold standard for treating high-risk cutaneous basal cell carcinoma (BCC), but is expensive, time-consuming, and can be unpredictable as to how many ...

Basal cell carcinoma is the most common malignancy in humans, and it is also the mostfrequent periocular malignancy. Although a slow-growing tumor, it can lead to significant morbidityin the ...